NCT04241653

Brief Summary

This study will be conducted to evaluate effects of different modes of ventilation on pediatric cataract surgery aiming to a peri-operative stable anesthesia, better surgical satisfaction and post operative recovery. It is hypothesized that controlled ventilation without muscle relaxation will be advantageous to other modes in providing adequate surgical satisfaction with considerable depth of anesthesia and better recovery profile.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2021

Completed
Last Updated

June 10, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

January 23, 2020

Last Update Submit

June 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of eye movements

    Incidence any upward or downward deviation of the vision axis during surgery will be recorded

    Up to the end of the surgery

Secondary Outcomes (8)

  • Changes in intraocular pressure

    Up to the end of the surgery

  • Changes in bispectral index

    Up to the end of the surgery

  • Amount of consumption of sevoflurane

    Up to the end of the surgery

  • Changes in dynamic compliance

    Up to the end of the surgery

  • Changes in heart rate

    Up to the end of the surgery

  • +3 more secondary outcomes

Study Arms (3)

Spontaneous Ventilation

ACTIVE COMPARATOR

Patients will spontaneously ventilated. Laryngeal mask airway will be inserted and anesthesia is maintained with sevoflurane.

Procedure: Pressure Support VentilationDevice: Laryngeal Mask AirwayDrug: Sevoflurane

Unparalyzed Controlled Ventilation

ACTIVE COMPARATOR

Patients will be mechanically ventilated without muscle relaxation.Laryngeal mask airway will be inserted and anesthesia is maintained with sevoflurane.

Procedure: Unparalyzed Pressure Control VentilationDevice: Laryngeal Mask AirwayDrug: Sevoflurane

Paralyzed Controlled Ventilation

ACTIVE COMPARATOR

Patients will be mechanically ventilated with muscle relaxation.Laryngeal mask airway will be inserted and anesthesia is maintained with sevoflurane.

Procedure: Paralyzed Pressure Control VentilationDevice: Laryngeal Mask AirwayDrug: Sevoflurane

Interventions

Ventilator will be adjusted to administer pressure at 10 cmH2O.

Also known as: Assisted Ventilation
Spontaneous Ventilation

Pressure controlled ventilation mode will be applied to obtain a volume of 8 ml/kg up to 20 cmH2O. The set respiratory rate will be 15 breaths/min then it is adjusted to achieve the end tidal CO2 levels between 35 and 40 mmHg as measured by capnography.

Also known as: Positive pressure Ventilation
Unparalyzed Controlled Ventilation

Pressure controlled ventilation mode will be applied to obtain a volume of 8 ml/kg up to 20 cmH2O. The set respiratory rate will be 15 breaths/min then it is adjusted to achieve the end tidal CO2 levels between 35 and 40 mmHg as measured by capnography. Also, neuromuscular blockade will be achieved.

Also known as: Positive pressure Ventilation
Paralyzed Controlled Ventilation

Capnography connected to laryngeal mask airway is introduced after adequate jaw relaxation; its size is chosen according to the body weight of the child.

Also known as: Supraglottic Airway Device
Paralyzed Controlled VentilationSpontaneous VentilationUnparalyzed Controlled Ventilation

Sevoflurane in air/oxygen mixture of 40% will be titrated to achieve adequate depth of anesthesia to maintain immobilization of the eye.

Also known as: Inhalational Anesthesia
Paralyzed Controlled VentilationSpontaneous VentilationUnparalyzed Controlled Ventilation

Eligibility Criteria

Age1 Year - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • American Society of Anesthesiology (ASA) I and II patients.
  • Scheduled for elective cataract surgery.

You may not qualify if:

  • Parental refusal of consent.
  • Contraindication to use of supraglottic airway device as gastroesophageal reflux and oropharyngeal pathology.
  • Hyperactive airway disease or respiratory diseases.
  • Children with developmental delays, mental or neurological disorders.
  • Bleeding or coagulation diathesis.
  • History of known sensitivity to the used anesthetics.
  • Previous surgery in the same eye.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia, Mansoura University Hospitals

Al Mansurah, Dakahlia Governorate, 35511, Egypt

Location

Related Publications (7)

  • Dias R, Dave N, Agrawal B, Baghele A. Correlation between bispectral index, end-tidal anaesthetic gas concentration and difference in inspired-end-tidal oxygen concentration as measures of anaesthetic depth in paediatric patients posted for short surgical procedures. Indian J Anaesth. 2019 Apr;63(4):277-283. doi: 10.4103/ija.IJA_653_18.

    PMID: 31000891BACKGROUND
  • Fudickar A, Gruenewald M, Fudickar B, Hill M, Wallenfang M, Hullemann J, Voss D, Caliebe A, Roider JB, Steinfath M, Treumer F. Immobilization during anesthesia for vitrectomy using a laryngeal mask without neuromuscular blockade versus endotracheal intubation and neuromuscular blockade. Minerva Anestesiol. 2018 Jul;84(7):820-828. doi: 10.23736/S0375-9393.17.12282-0. Epub 2017 Oct 12.

    PMID: 29027777BACKGROUND
  • Ghabach MB, El Hajj EM, El Dib RD, Rkaiby JM, Matta MS, Helou MR. Ventilation of Nonparalyzed Patients Under Anesthesia with Laryngeal Mask Airway, Comparison of Three Modes of Ventilation: Volume Controlled Ventilation, Pressure Controlled Ventilation, and Pressure Controlled Ventilation-volume Guarantee. Anesth Essays Res. 2017 Jan-Mar;11(1):197-200. doi: 10.4103/0259-1162.200238.

    PMID: 28298784BACKGROUND
  • Lewis SR, Pritchard MW, Fawcett LJ, Punjasawadwong Y. Bispectral index for improving intraoperative awareness and early postoperative recovery in adults. Cochrane Database Syst Rev. 2019 Sep 26;9(9):CD003843. doi: 10.1002/14651858.CD003843.pub4.

    PMID: 31557307BACKGROUND
  • Waldschmidt B, Gordon N. Anesthesia for pediatric ophthalmologic surgery. J AAPOS. 2019 Jun;23(3):127-131. doi: 10.1016/j.jaapos.2018.10.017. Epub 2019 Apr 14.

    PMID: 30995517BACKGROUND
  • Singh PM, Trikha A, Sinha R, Borle A. Measurement of consumption of sevoflurane for short pediatric anesthetic procedures: Comparison between Dion's method and Dragger algorithm. J Anaesthesiol Clin Pharmacol. 2013 Oct;29(4):516-20. doi: 10.4103/0970-9185.119160.

    PMID: 24249990BACKGROUND
  • Mason KP. Paediatric emergence delirium: a comprehensive review and interpretation of the literature. Br J Anaesth. 2017 Mar 1;118(3):335-343. doi: 10.1093/bja/aew477.

    PMID: 28203739BACKGROUND

MeSH Terms

Conditions

Respiratory Aspiration

Interventions

VentilationPositive-Pressure RespirationLaryngeal MasksSevoflurane

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Environment, ControlledEnvironmentEnvironment and Public HealthRespiration, ArtificialAirway ManagementTherapeuticsRespiratory TherapyIntubation, IntratrachealIntubationInvestigative TechniquesMasksProtective DevicesEquipment and SuppliesPersonal Protective EquipmentManufactured MaterialsTechnology, Industry, and AgricultureMethyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Officials

  • Sameh M El-Sherbiny, MD

    Mansoura Faculty of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of anesthesia, ICU & pain management; Faculty of Medicine

Study Record Dates

First Submitted

January 23, 2020

First Posted

January 27, 2020

Study Start

January 20, 2020

Primary Completion

January 10, 2021

Study Completion

February 9, 2021

Last Updated

June 10, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations